Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions • $1.8B total value
Manager:
Search and click to pin securities to the top
Page 3 of 11
Vaxcyte, Inc.
Shares:300.0K
Value:$11.3M
% of Portfolio:0.6% ($11.3M/$1.8B)
Keros Therapeutics, Inc.
Shares:1.1M
Value:$11.2M
% of Portfolio:0.6% ($11.2M/$1.8B)
Teladoc Health, Inc.
Shares:1.4M
Value:$11.1M
% of Portfolio:0.6% ($11.1M/$1.8B)
Journey Medical Corp
Shares:1.9M
Value:$10.9M
% of Portfolio:0.6% ($10.9M/$1.8B)
Vanda Pharmaceuticals Inc.
Shares:2.4M
Value:$10.8M
% of Portfolio:0.6% ($10.8M/$1.8B)
07725L102
Shares:37.0K
Value:$10.1M
% of Portfolio:0.6% ($10.1M/$1.8B)
ARVINAS, INC.
Shares:1.4M
Value:$9.8M
% of Portfolio:0.5% ($9.8M/$1.8B)
Harmony Biosciences Holdings, Inc.
Shares:281.2K
Value:$9.3M
% of Portfolio:0.5% ($9.3M/$1.8B)
Alibaba Group Holding Ltd
Shares:70.0K
Value:$9.3M
% of Portfolio:0.5% ($9.3M/$1.8B)
CRISPR Therapeutics AG
Shares:266.5K
Value:$9.1M
% of Portfolio:0.5% ($9.1M/$1.8B)
Moderna, Inc.
Shares:305.3K
Value:$8.7M
% of Portfolio:0.5% ($8.7M/$1.8B)
Cullinan Therapeutics, Inc.
Shares:1.1M
Value:$8.5M
% of Portfolio:0.5% ($8.5M/$1.8B)
Elanco Animal Health Inc
Shares:800.1K
Value:$8.4M
% of Portfolio:0.5% ($8.4M/$1.8B)
PLIANT THERAPEUTICS, INC.
Shares:6.0M
Value:$8.1M
% of Portfolio:0.4% ($8.1M/$1.8B)
Bausch & Lomb Corp
Shares:550.0K
Value:$8.0M
% of Portfolio:0.4% ($8.0M/$1.8B)
INSMED Inc
Shares:100.0K
Value:$7.6M
% of Portfolio:0.4% ($7.6M/$1.8B)
Phathom Pharmaceuticals, Inc.
Shares:1.2M
Value:$7.5M
% of Portfolio:0.4% ($7.5M/$1.8B)
Apogee Therapeutics, Inc.
Shares:200.0K
Value:$7.5M
% of Portfolio:0.4% ($7.5M/$1.8B)
HilleVax, Inc.
Shares:4.9M
Value:$7.1M
% of Portfolio:0.4% ($7.1M/$1.8B)
ImmunityBio, Inc.
Shares:2.3M
Value:$7.0M
% of Portfolio:0.4% ($7.0M/$1.8B)